Serotonin polymorphism

Arias, B., Catalan, R. et al. (2003). 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study. /. Clin. Psychopharmacol, 23(6), 563-7. 

Smeraldi, E., Zanardi, R. et al. (1998). Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol. Psychiatry, 3(6), 508-11. Wang, S. L., Huang, J. D. et al. (1993). Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects polymorphism in RFLP and DNA sequence of CYP2D6. Clin. Pharmacol. Ther., 53(4), 410-18. 

Yoshida, K., Ito, K. etal. (2002). Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry, 26(2), 383-6. 

Yu, Y. W., Tsai, S. J. etal. (2002). Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders. Mol. Psychiatry, 7(10), 1115-19. 

Kim, D.K.et al. (2000). Serotonin transporter gene polymorphism and antidepressant response. Neuroreport, 11,215-19. 

Ng, C. H., Easteal, S., Tan, S. et al. (2006b). Serotonin transporter polymorphisms and clinical response to sertraline across ethnicities. Progress in Neuropsychopharmacology and Biological... 

Smeraldi, E. et al. (1998). Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol. Psychiatry, 3, 508-11. 

Cusin, C., Serretti, A., Zanardi, R. etal. (2002). Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity. Int.. Neuropsychopharmacol, 5, 27-35. 

Durham, L. K., Webb, S. M., Milos, P. M., Clary, C. M. Seymour, A. B. (2004). The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder. Psychopharmacology, 174, 525-9. 

Lesch, K. P., Bengel, D., Heils, A. etal. (1996). Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region. Science, 274, 1527-31. 

Masellis, M., Basile, V. S., Meltzer, H. Y. etal. (2001). Lack of association between theT->C 267 serotonin 5-HT 6 receptor gene (HTR6) polymorphism andprediction of response to clozapine in schizophrenia. Schizophr. Res., 15, 49-58. 

Minov, C., Baghai, T.C., Schule, C. etal. (2001). Serotonin-2A-receptor and -transporter polymorphisms lack of association in patients with major depression. Neurosci. Lett., 303, 119-22. 

Reynolds, G. P., Zhang, Z. Zhang, X. (2003). Polymorphism of the promoter region of the serotonin 5HT(2C) receptor gene and clozapine induced weight gain. Am. J. Psychiatry, 160, 677-9. 

Zanardi, R., Benedetti, F., Di Bella, D., Catalano, M. Smeraldi, E. (2000). Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. /. Clin. Psychopharmacol., 20, 105-7. 

Wang, X. X., Mu, J. S. Wang, S. H. (2004). Association study of serotonin transporter gene polymorphism and depression. Chinese Journal of Clinical Psychiatry, 14(4), 195-7. 

Serretti, A., Benedetti, F., Zanardi, R. Smeraldi, E. (2005). The influence of serotonin transporter promoter polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments. Prog. Neuro psychopharmacol. Biol. Psychiatry, 29(6), 1074-84. 

---